FHA
LUNG icon

Flagship Harbor Advisors’s Pulmonx LUNG Stock Holding History

Flagship Harbor Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40,737
Closed -$1.86M – 664
2021
Q1 		$1.86M Buy
+40,737
New +$2.34M 0.21% 110

Other funds holding LUNG

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Flagship Harbor Advisors's LUNG Position: Q2 2021 in Review

Flagship Harbor Advisors sold out of Pulmonx (LUNG) in Q2 2021, closing a stake of 40,737 shares — an estimated $1.86M sold.

Flagship Harbor Advisors first reported a position in LUNG in Q1 2021 and held it in 1 quarter. The position peaked at $1.86M in Q1 2021. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2021.

  • Flagship Harbor Advisors reported no remaining Pulmonx position as of Q2 2021 after selling out during the quarter.
  • Flagship Harbor Advisors sold 40,737 Pulmonx shares in Q2 2021, an estimated $1.86M.
  • Flagship Harbor Advisors first reported a position in Pulmonx in Q1 2021 and held it in 1 quarter.
  • Flagship Harbor Advisors's Pulmonx position peaked at $1.86M in Q1 2021.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2021.

Based on Flagship Harbor Advisors's 13F filing for Q2 2021, filed 26 Jul 2021.